Annual CFI
-$1.93 M
+$533.00 K+21.63%
December 31, 2024
Summary
- As of March 12, 2025, KROS annual cash flow from investing activities is -$1.93 million, with the most recent change of +$533.00 thousand (+21.63%) on December 31, 2024.
- During the last 3 years, KROS annual CFI has fallen by -$907.00 thousand (-88.57%).
- KROS annual CFI is now -789.86% below its all-time high of -$217.00 thousand, reached on December 31, 2018.
Performance
KROS Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
-$289.00 K
+$97.00 K+25.13%
December 31, 2024
Summary
- As of March 12, 2025, KROS quarterly cash flow from investing activities is -$289.00 thousand, with the most recent change of +$97.00 thousand (+25.13%) on December 31, 2024.
- Over the past year, KROS quarterly CFI has stayed the same.
Performance
KROS Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
-$1.93 M
+$252.00 K+11.54%
December 31, 2024
Summary
- As of March 12, 2025, KROS TTM cash flow from investing activities is -$1.93 million, with the most recent change of +$252.00 thousand (+11.54%) on December 31, 2024.
- Over the past year, KROS TTM CFI has stayed the same.
Performance
KROS TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
KROS Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +21.6% | 0.0% | 0.0% |
| 3 y3 years | -88.6% | -81.8% | -88.6% |
| 5 y5 years | -612.5% | -1505.6% | -612.5% |
KROS Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -88.6% | +21.6% | -96.6% | +72.8% | -100.9% | +21.6% |
| 5 y | 5-year | -612.5% | +21.6% | -1505.6% | +72.8% | -666.3% | +21.6% |
| alltime | all time | -789.9% | +21.6% | <-9999.0% | +72.8% | <-9999.0% | +21.6% |
Keros Therapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$1.93 M(-21.6%) | -$289.00 K(-25.1%) | -$1.93 M(-11.5%) |
| Sep 2024 | - | -$386.00 K(+24.5%) | -$2.18 M(-7.0%) |
| Jun 2024 | - | -$310.00 K(-67.2%) | -$2.35 M(-0.0%) |
| Mar 2024 | - | -$946.00 K(+74.9%) | -$2.35 M(-4.7%) |
| Dec 2023 | -$2.46 M(+98.5%) | -$541.00 K(-1.6%) | -$2.46 M(+8.4%) |
| Sep 2023 | - | -$550.00 K(+76.8%) | -$2.27 M(+19.7%) |
| Jun 2023 | - | -$311.00 K(-70.7%) | -$1.90 M(-11.9%) |
| Mar 2023 | - | -$1.06 M(+202.6%) | -$2.16 M(+73.7%) |
| Dec 2022 | -$1.24 M(+21.2%) | -$351.00 K(+99.4%) | -$1.24 M(+18.3%) |
| Sep 2022 | - | -$176.00 K(-69.0%) | -$1.05 M(+3.0%) |
| Jun 2022 | - | -$567.00 K(+285.7%) | -$1.02 M(+5.9%) |
| Mar 2022 | - | -$147.00 K(-7.5%) | -$961.00 K(-6.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$1.02 M(+248.3%) | -$159.00 K(+9.7%) | -$1.02 M(+10.7%) |
| Sep 2021 | - | -$145.00 K(-71.6%) | -$925.00 K(+14.2%) |
| Jun 2021 | - | -$510.00 K(+142.9%) | -$810.00 K(+147.0%) |
| Mar 2021 | - | -$210.00 K(+250.0%) | -$328.00 K(+11.6%) |
| Dec 2020 | -$294.00 K(+8.5%) | -$60.00 K(+100.0%) | -$294.00 K(+16.7%) |
| Sep 2020 | - | -$30.00 K(+7.1%) | -$252.00 K(-17.1%) |
| Jun 2020 | - | -$28.00 K(-84.1%) | -$304.00 K(-32.0%) |
| Mar 2020 | - | -$176.00 K(+877.8%) | -$447.00 K(+64.9%) |
| Dec 2019 | -$271.00 K(+24.9%) | -$18.00 K(-78.0%) | -$271.00 K(+7.1%) |
| Sep 2019 | - | -$82.00 K(-52.0%) | -$253.00 K(+48.0%) |
| Jun 2019 | - | -$171.00 K(<-9900.0%) | -$171.00 K(<-9900.0%) |
| Mar 2019 | - | $0.00 | $0.00 |
| Dec 2018 | -$217.00 K | - | - |
FAQ
- What is Keros Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for Keros Therapeutics?
- What is Keros Therapeutics annual CFI year-on-year change?
- What is Keros Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Keros Therapeutics?
- What is Keros Therapeutics quarterly CFI year-on-year change?
- What is Keros Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for Keros Therapeutics?
- What is Keros Therapeutics TTM CFI year-on-year change?
What is Keros Therapeutics annual cash flow from investing activities?
The current annual CFI of KROS is -$1.93 M
What is the all time high annual CFI for Keros Therapeutics?
Keros Therapeutics all-time high annual cash flow from investing activities is -$217.00 K
What is Keros Therapeutics annual CFI year-on-year change?
Over the past year, KROS annual cash flow from investing activities has changed by +$533.00 K (+21.63%)
What is Keros Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of KROS is -$289.00 K
What is the all time high quarterly CFI for Keros Therapeutics?
Keros Therapeutics all-time high quarterly cash flow from investing activities is $0.00
What is Keros Therapeutics quarterly CFI year-on-year change?
Over the past year, KROS quarterly cash flow from investing activities has changed by $0.00 (0.00%)
What is Keros Therapeutics TTM cash flow from investing activities?
The current TTM CFI of KROS is -$1.93 M
What is the all time high TTM CFI for Keros Therapeutics?
Keros Therapeutics all-time high TTM cash flow from investing activities is $0.00
What is Keros Therapeutics TTM CFI year-on-year change?
Over the past year, KROS TTM cash flow from investing activities has changed by $0.00 (0.00%)